Beijing Science Sun Pharmaceutical Co Ltd Capital Reinvestment Ratio

Latest as of September 2025: 0.54x

Beijing Science Sun Pharmaceutical Co Ltd capital reinvestment ratio. Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Capital Reinvestment Ratio of 0.54x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥28.68 Million) in capital expenditures (CN¥15.52 Million). Check Beijing Science Sun Pharmaceutical Co Lt (300485) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.54x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥28.68 Million
CNY

Capital Expenditures

CN¥15.52 Million
CNY

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Beijing Science Sun Pharmaceutical Co Ltd (2011–2025)

Capital reinvestment ratio of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2025. This chart tracks Beijing Science Sun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 15 annual periods. Also explore Beijing Science Sun Pharmaceutical Co Lt net asset momentum to track the company's year-over-year net asset growth rate.

Beijing Science Sun Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2011–2025)

Beijing Science Sun Pharmaceutical Co Ltd capital reinvestment ratio by year from 2011 to 2025. For the full cash flow conversion analysis, see Beijing Science Sun Pharmaceutical Co Lt (300485) cash flow conversion.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 3.70x CN¥27.08 Million CN¥100.28 Million ▲ +397.9%
2024 0.74x CN¥135.97 Million CN¥101.13 Million ▼ -70.2%
2023 2.49x CN¥21.21 Million CN¥52.91 Million ▲ +536.5%
2022 0.39x CN¥110.43 Million CN¥43.28 Million ▲ +56.5%
2021 0.25x CN¥183.30 Million CN¥45.91 Million ▼ -43.9%
2020 0.45x CN¥263.73 Million CN¥117.84 Million ▼ -30.8%
2019 0.65x CN¥172.52 Million CN¥111.42 Million ▼ -52.2%
2018 1.35x CN¥146.52 Million CN¥198.00 Million ▲ +3.5%
2017 1.31x CN¥108.21 Million CN¥141.25 Million ▲ +89.0%
2016 0.69x CN¥212.89 Million CN¥147.00 Million ▲ +269.4%
2015 0.19x CN¥169.36 Million CN¥31.65 Million ▲ +342.6%
2014 0.04x CN¥214.23 Million CN¥9.05 Million ▼ -57.2%
2013 0.10x CN¥196.82 Million CN¥19.42 Million ▼ -81.4%
2012 0.53x CN¥151.93 Million CN¥80.76 Million ▲ +50.1%
2011 0.35x CN¥77.06 Million CN¥27.29 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow